Wang J - Search Results

1

Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers.

Li Y, Zhao B, Peng J, Tang H, Wang S, Peng S, Ye F, Wang J, Ouyang K, Li J, Cai M, Chen Y. Li Y, et al. Among authors: wang j, wang s. Drug Resist Updat. 2024 Mar;73:101042. doi: 10.1016/j.drup.2023.101042. Epub 2024 Jan 4. Drug Resist Updat. 2024. PMID: 38219532 Free article. Review.

2

Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3).

Shi Y, Wu L, Yu X, Xing P, Wang Y, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y, Yuan Y, Feng J, Chen Z, Shi J, Sun T, Wu G, Shu Y, Guo Q, Zhang Y, Song Y, Zhang S, Chen Y, Li W, Niu H, Hu W, Wang L, Huang J, Zhang Y, Cheng Y, Wu Z, Peng B, Sun J, Mancao C, Wang Y, Sun L. Shi Y, et al. Among authors: wang l, wang z, wang j, wang y, wang m, wang c, wang a. Cancer Commun (Lond). 2022 Dec;42(12):1314-1330. doi: 10.1002/cac2.12385. Epub 2022 Nov 6. Cancer Commun (Lond). 2022. PMID: 36336841 Free PMC article. Clinical Trial.

3

Long Non-Coding RNA OIP5-AS1 Inhibits the Proliferation and Migration of Esophageal Squamous Carcinoma Cells by Targeting FOXD1/miR-30a-5p Axis and the Effect of Micro- and Nano-Particles on Targeting Transfection System.

Yan Q, Liu L, Yang H, Xu C, Wang Z, Wang Q, Wu Z, Wu C, Dong L, Wang J, Wu M. Yan Q, et al. Among authors: wang z, wang j, wang q. J Biomed Nanotechnol. 2021 Jul 1;17(7):1380-1391. doi: 10.1166/jbn.2021.3114. J Biomed Nanotechnol. 2021. PMID: 34446141

4

Cuproptosis/OXPHOS tendency prediction of prognosis and immune microenvironment of esophageal squamous cell carcinoma: Bioinformatics analysis and experimental validation.

Li L, Cheng H, Gong L, Huang Y, Yang J, Yan Q, Dai S, Wang J. Li L, et al. Among authors: wang j. Gene. 2024 Apr 15;902:148156. doi: 10.1016/j.gene.2024.148156. Epub 2024 Jan 9. Gene. 2024. PMID: 38211899

5

Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1.

Huang XP, Li X, Situ MY, Huang LY, Wang JY, He TC, Yan QH, Xie XY, Zhang YJ, Gao YH, Li YH, Rong TH, Wang MR, Cai QQ, Fu JH. Huang XP, et al. Cancer Lett. 2018 Feb 1;414:294-300. doi: 10.1016/j.canlet.2017.10.023. Epub 2017 Dec 5. Cancer Lett. 2018. PMID: 29107111

6

A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma.

Duan F, Wang W, Zhai W, Wang J, Zhao Z, Zheng L, Rao B, Zhou Y, Long H, Lin Y. Duan F, et al. Among authors: wang w, wang j. Front Genet. 2022 Dec 14;13:1078790. doi: 10.3389/fgene.2022.1078790. eCollection 2022. Front Genet. 2022. PMID: 36588791 Free PMC article.

7

Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer.

Lai Y, Wang X, Zeng T, Xing S, Dai S, Wang J, Chen S, Li X, Xie Y, Zhu Y, Liu W. Lai Y, et al. Among authors: wang x, wang j. J Cancer. 2018 Apr 6;9(9):1538-1547. doi: 10.7150/jca.23973. eCollection 2018. J Cancer. 2018. PMID: 29760791 Free PMC article.

8

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.

Zhai WY, Duan FF, Chen S, Wang JY, Lin YB, Wang YZ, Rao BY, Zhao ZR, Long H. Zhai WY, et al. Front Genet. 2022 Jan 5;12:798131. doi: 10.3389/fgene.2021.798131. eCollection 2021. Front Genet. 2022. PMID: 35069695 Free PMC article.

9

Integrative Analysis of Bioinformatics and Machine Learning Algorithms Identifies a Novel Diagnostic Model Based on Costimulatory Molecule for Predicting Immune Microenvironment Status in Lung Adenocarcinoma.

Zhai WY, Duan FF, Wang YZ, Wang JY, Zhao ZR, Lin YB, Rao BY, Chen S, Zheng L, Long H. Zhai WY, et al. Am J Pathol. 2022 Oct;192(10):1433-1447. doi: 10.1016/j.ajpath.2022.06.015. Epub 2022 Aug 7. Am J Pathol. 2022. PMID: 35948079 Free article.

10

Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.

Zhai W, Duan F, Li D, Yan Q, Dai S, Zhang B, Wang J. Zhai W, et al. Among authors: wang j. Eur J Surg Oncol. 2022 Apr;48(4):752-760. doi: 10.1016/j.ejso.2021.09.023. Epub 2021 Oct 4. Eur J Surg Oncol. 2022. PMID: 34620508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203,028 results

Search Page